Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Not applicable

Child Cognitive-Affective Resilience Following 13-11 Event : A Pluridisciplinary Study of Intergenerational Transmission of a Traumatic Event

NCT07203443 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2024-12-17
Last updated
2026-10-19

Condition(s) studied

Intergenerational Trauma

Investigational drug(s) / intervention(s)

MRIPsychological assessmentCognitive assessmentCortisol sample

MRI: Anatomical and functional MRI

Psychological assessment: Inventories and clinical interviews

Cognitive assessment: Attention and memory tests

Cortisol sample: Salivary test

Study summary

CARE 13-11 study explores the transmission of trauma within families. Exposure to a traumatic event can have an impact on those directly exposed, but also on their family.

This transmission is both biological and behavioral, leading to adaptation that is still poorly understood. CARE 13-11 project offers a unique opportunity to bring together different disciplinary fields, from neuroscience to human and social sciences, to understand this phenomenon.

To answer these questions, the study includes directly exposed families with minor children born before the events, as well as families with no exposure to these events (the so-called "control" group).

Eligibility

Sex
ALL
Min age
9 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: Exposed group Children * Minor child born before November 13, 2015 * At least one parent was present at the scene of the attacks: criteria A1 (directly exposed to the event) or exposed to the event) or A2 (witnessed the event) of DSM-5 * With a good command of the French language (francophone) * Whose parents have given written consent for their child's their child's participation * At least one parent is covered by health insurance Parent 1 (and Parent 3) * Parent of child(ren) included * Directly exposed to the attacks: present at the scene of the attacks: criteria A1 (directly exposed to the event) or to the event) or A2 (witness to the event) of the DSM-5 * Good command of the French language * Affiliated with or benefiting from a social security scheme * Has given written consent Parent 2 * Parent of child(ren) included * Not exposed but whose spouse (or ex-spouse) was directly exposed to the attacks on a declarative basis * Have a good command of the French language * Affiliated with a social security scheme or beneficiary of such a scheme * Having given written consent Uncle/aunt * Not exposed, but has a brother or sister directly exposed to the attacks * Have a good command of the French language * Beneficiary of health insurance * Having given written consent Cousin * Minor child born before November 13, 2015 * Whose aunt or uncle was directly exposed to the attacks * Child with a good command of the French language * Who has given written consent * Whose parents with parental authority have given written consent for their child's their child's participation * Whose parent is affiliated to a social security scheme or is a beneficiary of such a scheme Unexposed group Child * Minor child born before November 13, 2015 * No relative (family or close friend) has been exposed to the attacks * With a good command of the French language * Whose parents have given their written consent for their child's their child's participation * One of whose parents is affiliated to or benefits from a social security scheme Parent 1 * Parent of child(ren) included * No exposure to the attacks and no close relative (family or close friend) exposed to the attacks attacks * No PTSD at the time of inclusion (PCL-5 \< 33) * Have a good command of the French language * Affiliated with or benefiting from a social security scheme * Having given written consent Parent 2 * Parent of included child(ren) * No exposure to terrorist attacks * With a good command of the French language * Affiliated with or benefiting from a social security scheme * Having given written consent Exclusion Criteria: For all children: * Loss of both parents following the events of November 13 * Presence of a history of severe neurological, mental or psychopathological disorders (epilepsy, head trauma with loss of consciousness of more than one hour, autism spectrum disorder, intellectual disability, schizophrenia) * Persons subject to a legal protection measure (safeguard of justice, curatorship, guardianship) * Subject to a period of exclusion in the context of another research project * Refusal of the child to participate in research For children undergoing the on-site protocol: * Person with contraindications to MRI * For women of childbearing age, pregnancy in progress * Psychotropic products capable of modifying attention, vigilance and concentration taken less than 24 hours before questionnaires or examinations (sleeping pills and hypnotics, antipsychotics, mood regulators, antiepileptics and antihistamines). If in doubt about the patient's ability the patient's ability to postpone treatment, advice should be sought from the attending physician. in the case of antipsychotics and antiepileptics For all parents: * Presence of a history of neurological or neurodevelopmental disorders prior to the attacks except ADHD (epilepsy, head trauma with loss of consciousness of more than one hour, autism spectrum disorder autism spectrum disorder, intellectual disability, schizophrenia) * Persons subject to a legal protection measure (safeguard of justice, curatorship, guardianship) * Subject to a period of exclusion in the context of another research project * Parent's refusal to participate in research For parents carrying out the protocol on site: * Person with contraindications to MRI * For women of childbearing age, current or planned pregnancy * Psychotropic products capable of modifying attention, vigilance and concentration taken less than 24 hours before questionnaires or examinations (sleeping pills and hypnotics, antipsychotics, mood regulators, antiepileptics and antihistamines). If in doubt about the patient's ability the patient's ability to postpone treatment, advice should be sought from the attending physician. in the case of antipsychotics and antiepileptics

Primary outcome measure(s)

  • Assessment of Psychiatric nosography with MINI (parents) — During the one day of assessments
    Psychological interview
  • Assessment of PTSD symptoms severity in children 8-11 years and 12-17 years — During the one day of assessments
    Results from CPSS-5 a semi-structered interview
  • Assesssment of PTSD symptoms for parents and children over the age of 18 — During the one day of assessments
    Results from SCID-5-CV which is a semi-structered interview for the diagnosis of mental disorders DSM-5
  • Assessment of PTSD symptoms severity in adults — During the one day of assessments
    Scores from PCL-5 which is a self report measure
  • Secondary traumatisation — During the one day of assessments
    Parents and children : Scores from FST
  • Post-traumatic growth — During the one day of assessments
    Parents : Scores from PTGI
  • Coping skills for parents, children 12-17 years and over the age of 18 — During the one day of assessments
    Scores from BCI
  • Coping skills for parents and children 8-11 years — During the one day of assessments
    Scores from SRCS.
  • Resilience for parents and children over the age of 18 — During the one day of assessments
    Scores from ARM-R
  • Resilience for children 8 to 11 years old — During the one day of assessments
    Scores from CYRM-R-Child
  • Resilience for children 12 to 17 years old — During the one day of assessments
    Scores from CYRM-R-Youth
  • Attachment — During the one day of assessments
    Children : Scores from IPPA
  • Anxiety — During the one day of assessments
    Parents : scores from STAI
  • Depression — During the one day of assessments
    Parents : scores from BDI
  • Self-esteem — During the one day of assessments
    Parents : scores from SPP-Adult
  • Emotion regulation for parents and children over the age of 18 — During the one day of assessments
    Scores from ERQ
  • Emotion regulation for Children and adolescents aged 8 to 17 — During the one day of assessments
    Scores from ERQ-CA
  • Empathy for Parents, chidren 12-17 years and children over the age of 18 — During the one day of assessments
    Scores from BES-A
  • Empathy for Children 8-11 years — During the one day of assessments
    Scores from BES-C
  • World vision — During the one day of assessments
    Parents and children : scores from WAS
  • Well being — During the one day of assessments
    Parents and children : score from WHO-5
  • Assessment of Psychiatric nosography with CBCL/YSR (children) — During the one day of assessments
    Total score, Main scales: Internalized behaviours, Externalized behaviours, Subscales: Anxiety/Depression, Social withdrawal, Somatic complaints, Interpersonal problems, Thought disorder, Attention deficit disorder, Deviant behaviours, Aggressive behaviours, Other problems
  • Social support — During the one day of assessments
    Parents : scores from Social Support Questionnaire
  • Cognitive avoidance — During the one day of assessments
    Parents and children : scores from QEC
  • Bonding — During the one day of assessments
    Parents and children : scores from PBI
  • Familial functionning — During the one day of assessments
    Parents and children :Scores from the FAD-SF
  • Parenting style and practices — During the one day of assessments
    Parents and children : Scores from the APQ
  • Communication about 13-11 Event — During the one day of assessments
    Parents and children : results from Communication about 13-11 Event Interview
  • Attention — During the one day of assessments
    Parents and children : scores from the Attentional Network Test
  • Transmission of traumatic memory — During the one day of assessments
    Parents and children : results from the Approach-Avoidance Task
  • Executive functionning — During the one day of assessments
    Children : scores from BRIEF
  • Cortisol — During the morning of the one day of assessments
    Parents and children : Cortisol Awakening Response
  • Sleep - questionnaires for children 8-11 and 12-17 years — During the one day of assessments
    Scores from SDSC
  • Sleep - questionnaires for Parents and children over the age of 18 — During the one day of assessments
    Scores from PSQI
  • Sleep - questionnaires for Parents and children over the age of 18 — During the one day of assessments
    Scores from ISI
  • Sleep - actimetry Parents and children — One week before the one day of assessments
    Measurement of bedtimes and wake-up times using an actimeter (a wrist-worn watch-size device).
  • Sleep - planner Parents and children — One week before the one day of assessments
    Evalustion of the sleep diary
  • Neuroanatomical analysis — During the one day of assessments
    Parents and children : anatomic MRI with the classic anatomical sequences
  • Neurofunctional analysis — During the one day of assessments
    Parents and children fonctionnal MRI with the measurement of the magnitude of the BOLD signal

Trial sites (1)

FacilityCityRegionStatus
Umr-S 1077 Nimh Caen France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07203443 on ClinicalTrials.gov ↗ ← All trials in France